Neurogenic Detrusor Overactivity Global Market Report 2025
상품코드:1769672
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
신경성 방광근 과활동 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 신경 장애는 뇌, 척수 또는 신경에 영향을 미치는 의학적 상태로, 운동, 감각, 인지 또는 기타 신체 기능에 문제를 일으킵니다. 인구 고령화로 인해 뇌 퇴화 위험이 증가함에 따라 이러한 질환의 유병률도 높아지고 있습니다. NDO는 척수 손상, 다발성 경화증, 파킨슨병 등 신경계 질환과 연관된 방광 기능 장애의 한 형태입니다. 이러한 질환은 뇌와 방광 사이의 정상적인 신경 신호 전달을 방해해 방광의 비자발적 수축을 유발합니다.
신경성 방광근 과활동 치료에 종사하는 주요 기업들은 저렴한 비용으로 효과적인 방광 조절 솔루션을 제공하기 위해 베타-3 아드레날린 수용체 작용제 등 첨단 제네릭 치료제 개발을 강조하고 있습니다. 미라베그론과 같은 이러한 의약품은 방광의 배뇨근을 이완시켜 방광 용량을 늘리고 절박감 및 요실금과 같은 증상을 완화합니다. 예를 들어, 2024년 4월, 인도 제약 회사인 Lupin Ltd.는 미국 식품의약국(USFDA)으로부터 Myrbetriq의 제네릭 의약품인 Mirabegron을 미국에서 출시할 수 있는 승인을 받았습니다. 1일 1회 경구 투여하는 Mirabegron은 소아 환자의 과민성 방광(OAB) 및 신경성 방광근 과활동을 관리하기 위한 편리하고 효율적인 옵션입니다. 이 승인은 루핀이 핵심 치료 분야에서 고품질 및 저렴한 제네릭 의약품을 제공하기 위한 노력을 강조합니다.
2024년 11월, 미국 의료기기 기업 보스턴 사이언티픽 코퍼레이션(Boston Scientific Corporation)은 신경 조절 및 비뇨기과 분야 포트폴리오를 강화하기 위해 액소닉스 인크(Axonics, Inc.)를 인수했습니다. 이 인수는 Axonics의 혁신적인 천골 신경 조절 기술을 통합하여 과민성 방광 및 기타 비뇨기 및 장 기능 장애 치료에 대한 Boston Scientific의 역량을 강화하기 위한 것입니다. Axonics의 솔루션을 통합함으로써 Boston Scientific은 골반 건강 상태에 대해 보다 포괄적인 치료 옵션을 제공할 수 있게 될 것입니다. Axonics, Inc.는 방광 조절을 개선하기 위해 설계된 천골 신경 조절 시스템을 전문으로 하는 미국에 본사를 둔 의료 기술 회사입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 신경성 방광근 과활동 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 신경성 방광근 과활동 시장 : 성장률 분석
세계의 신경성 방광근 과활동 시장 실적 : 규모와 성장(2019-2024년)
세계의 신경성 방광근 과활동 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 신경성 방광근 과활동 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 신경성 방광근 과활동 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
비외과적 치료
외과적 치료
후속 치료
세계의 신경성 방광근 과활동 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
성인용
어린이
세계의 신경성 방광근 과활동 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
비뇨기과 클리닉
재활센터
개인 진료소
장기 케어 시설
세계의 신경성 방광근 과활동 시장 : 비외과적 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
항무스카린약
β3 아드레날린 작용제
행동요법
신경조절
청결 간헐 카테터법
방광내 요법
세계의 신경성 방광근 과활동 시장 : 외과적 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
보툴리눔툭신(보톡스) 주사
방광증대술
요로 변경
외괄약근절개술
인공 요도 괄약근 이식
세계의 신경성 방광근 과활동 시장 : 후속 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
소변 유동태 평가
초음파 모니터링
임상 검사
지속적인 카테터 삽입
보툴리눔툭신(보톡스)의 반복 주사
환자와 간병인에게의 훈련
생활의 질의 평가
제7장 지역별, 국가별 분석
세계의 신경성 방광근 과활동 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 신경성 방광근 과활동 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
신경성 방광근 과활동 시장 : 경쟁 구도
신경성 방광근 과활동 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson Services Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Medtronic plc : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Teva Pharmaceutical Industries Ltd.
Astellas Pharma Inc.
Intas Pharmaceuticals Ltd.
Macleods Pharmaceuticals Ltd.
Sun Pharmaceutical Industries
Apotex Inc.
Viatris Inc.
Sumitomo Pharma America Inc.
Galderma
Ipsen
Coloplast A/S
Aurobindo Pharma Limited
Hisamitsu Pharmaceutical Co. Inc.
Kaken Pharmaceutical Co. Ltd.
Hugel Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
신경성 방광근 과활동 시장(2029년) : 새로운 기회를 제공하는 국가
신경성 방광근 과활동 시장(2029년) : 새로운 기회를 제공하는 부문
신경성 방광근 과활동 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Neurogenic detrusor overactivity (NDO) is a bladder dysfunction that results from neurological conditions interfering with normal nerve signals between the brain, spinal cord, and the bladder's detrusor muscle. This disruption causes increased or involuntary contractions of the detrusor muscle, leading to symptoms such as urinary urgency, frequent urination, urge incontinence, and occasionally incomplete bladder emptying.
The primary treatment options for neurogenic detrusor overactivity (NDO) include non-surgical treatments, surgical interventions, and follow-up care. Non-surgical treatments involve medical management or therapies that address the condition without requiring invasive surgical procedures. These treatments are utilized across different patient groups, including both adults and children, and are delivered in various settings such as hospitals, urology clinics, rehabilitation centers, private practices, and long-term care facilities.
The neurogenic detrusor overactivity market research report is one of a series of new reports from The Business Research Company that provides neurogenic detrusor overactivity market statistics, including the neurogenic detrusor overactivity industry global market size, regional shares, competitors with the neurogenic detrusor overactivity market share, detailed neurogenic detrusor overactivity market segments, market trends, and opportunities, and any further data you may need to thrive in the neurogenic detrusor overactivity industry. These neurogenic detrusor overactivity market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The neurogenic detrusor overactivity market size has grown strongly in recent years. It will grow from $1.69 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The historic growth is attributed to a rise in neurological disorders, increased awareness among healthcare providers, broader adoption of pharmaceutical treatments, development of hospital and clinic facilities, and higher diagnosis rates.
The neurogenic detrusor overactivity market size is expected to see strong growth in the next few years. It will grow to $2.45 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. Growth drivers for the forecast period include the aging population, rising cases of spinal cord injuries, increased healthcare spending, advancements in minimally invasive therapies, and enhanced patient awareness and education. Key trends during this period include technological progress in stem cell therapies, innovation in drug delivery systems, improvements in neuromodulation devices, advances in personalized medicine research, and the development of less invasive treatment procedures.
The rising incidence of neurological disorders is expected to drive the growth of the neurogenic detrusor overactivity (NDO) market in the coming years. Neurological disorders are medical conditions that affect the brain, spinal cord, or nerves, resulting in issues with movement, sensation, cognition, or other bodily functions. As people live longer, the likelihood of age-related brain degeneration increases, contributing to the growing prevalence of these conditions. NDO is a form of bladder dysfunction often linked to neurological disorders such as spinal cord injury, multiple sclerosis, and Parkinson's disease. These conditions interfere with normal nerve communication between the brain and bladder, leading to involuntary bladder contractions. For example, in April 2024, a study published by the American Academy of Neurology (AAN) indicated that there will be an estimated 4.9 billion cases of brain disorders globally by 2050, marking a 22% increase from around 4 billion cases in 2021. Consequently, the increasing number of neurological disorders is contributing to the expansion of the NDO market.
Major companies involved in the treatment of neurogenic detrusor overactivity are emphasizing the development of advanced generic therapies, such as beta-3 adrenergic receptor agonists, to provide effective bladder control solutions at lower costs. These drugs, such as mirabegron, help relax the detrusor muscle in the bladder, thereby enhancing bladder capacity and reducing symptoms like urgency and incontinence. For instance, in April 2024, Lupin Ltd., an Indian pharmaceutical company, received approval from the U.S. Food and Drug Administration (USFDA) to launch Mirabegron, a generic version of Myrbetriq, in the United States. As a once-daily oral treatment, Mirabegron provides a convenient and efficient option for managing overactive bladder (OAB) and neurogenic detrusor overactivity in pediatric patients. This approval underscores Lupin's commitment to offering high-quality and affordable generic medications in key therapeutic areas.
In November 2024, Boston Scientific Corporation, a U.S.-based medical device company, acquired Axonics, Inc. to strengthen its portfolio in neuromodulation and urology. This acquisition aims to enhance Boston Scientific's capabilities in treating overactive bladder and other urinary and bowel dysfunctions by incorporating Axonics' innovative sacral neuromodulation technologies. The integration of Axonics' solutions will allow Boston Scientific to offer more comprehensive care options for pelvic health conditions. Axonics, Inc. is a U.S.-based medical technology firm that specializes in sacral neuromodulation systems designed to improve bladder control.
Major players in the neurogenic detrusor overactivity market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi S. A., Medtronic plc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Intas Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries, Apotex Inc., Viatris Inc., Sumitomo Pharma America Inc., Galderma, Ipsen, Coloplast A/S, Aurobindo Pharma Limited, Hisamitsu Pharmaceutical Co. Inc., Kaken Pharmaceutical Co. Ltd., and Hugel Inc.
North America was the largest region in the neurogenic detrusor overactivity market in 2024. The regions covered in neurogenic detrusor overactivity report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the neurogenic detrusor overactivity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The neurogenic detrusor overactivity market includes revenues earned by entities by providing services such as medication management, behavioral and lifestyle interventions, physiotherapy, absorbent products and skin care, and catheterization. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neurogenic Detrusor Overactivity Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on neurogenic detrusor overactivity market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for neurogenic detrusor overactivity ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurogenic detrusor overactivity market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Types: Non-Surgical Treatment; Surgical Treatment; Follow-Up Treatment
2) By Application: Adult; Child
3) By End-User: Hospitals; Urology Clinics; Rehabilitation Centers; Private Practices; Long-Term Care Facilities
3. Neurogenic Detrusor Overactivity Market Trends And Strategies
4. Neurogenic Detrusor Overactivity Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Neurogenic Detrusor Overactivity Growth Analysis And Strategic Analysis Framework
5.1. Global Neurogenic Detrusor Overactivity PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Neurogenic Detrusor Overactivity Market Growth Rate Analysis
5.4. Global Neurogenic Detrusor Overactivity Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Neurogenic Detrusor Overactivity Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Neurogenic Detrusor Overactivity Total Addressable Market (TAM)
6.1. Global Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Surgical Treatment
Surgical Treatment
Follow-Up Treatment
6.2. Global Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult
Child
6.3. Global Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Urology Clinics
Rehabilitation Centers
Private Practices
Long-Term Care Facilities
6.4. Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Non-Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antimuscarinic Drugs
Beta-3 Adrenergic Agonists
Behavioral Therapy
Neuromodulation
Clean Intermittent Catheterization
Intravesical Therapies
6.5. Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Botulinum Toxin Injection
Augmentation Cystoplasty
Urinary Diversion
External Sphincterotomy
Artificial Urinary Sphincter Implantation
6.6. Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Follow-Up Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urodynamic Evaluation
Ultrasound Monitoring
Laboratory Tests
Ongoing Catheterization
Repeat Botulinum Toxin Injections
Patient and Caregiver Training
Quality of Life Assessment
7. Neurogenic Detrusor Overactivity Market Regional And Country Analysis
7.1. Global Neurogenic Detrusor Overactivity Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Neurogenic Detrusor Overactivity Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Neurogenic Detrusor Overactivity Market
9.1. China Neurogenic Detrusor Overactivity Market Overview
9.2. China Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Neurogenic Detrusor Overactivity Market
10.1. India Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Neurogenic Detrusor Overactivity Market
11.1. Japan Neurogenic Detrusor Overactivity Market Overview
11.2. Japan Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Neurogenic Detrusor Overactivity Market
12.1. Australia Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Neurogenic Detrusor Overactivity Market
13.1. Indonesia Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Neurogenic Detrusor Overactivity Market
14.1. South Korea Neurogenic Detrusor Overactivity Market Overview
14.2. South Korea Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Neurogenic Detrusor Overactivity Market
15.1. Western Europe Neurogenic Detrusor Overactivity Market Overview
15.2. Western Europe Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Neurogenic Detrusor Overactivity Market
16.1. UK Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.1. Germany Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Neurogenic Detrusor Overactivity Market
18.1. France Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Neurogenic Detrusor Overactivity Market
19.1. Italy Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Neurogenic Detrusor Overactivity Market
20.1. Spain Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Neurogenic Detrusor Overactivity Market
21.1. Eastern Europe Neurogenic Detrusor Overactivity Market Overview
21.2. Eastern Europe Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Neurogenic Detrusor Overactivity Market
22.1. Russia Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Neurogenic Detrusor Overactivity Market
23.1. North America Neurogenic Detrusor Overactivity Market Overview
23.2. North America Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Neurogenic Detrusor Overactivity Market
24.1. USA Neurogenic Detrusor Overactivity Market Overview
24.2. USA Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Neurogenic Detrusor Overactivity Market
26.1. South America Neurogenic Detrusor Overactivity Market Overview
26.2. South America Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Neurogenic Detrusor Overactivity Market
27.1. Brazil Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Neurogenic Detrusor Overactivity Market
28.1. Middle East Neurogenic Detrusor Overactivity Market Overview
28.2. Middle East Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Neurogenic Detrusor Overactivity Market
29.1. Africa Neurogenic Detrusor Overactivity Market Overview
29.2. Africa Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Neurogenic Detrusor Overactivity Market Competitive Landscape And Company Profiles
